Fortive (FTV) was spun-off from Danaher in July 2016 at which time it had reported FY2015 annual revenue of ~$6.2B. After FTV became a separate publicly traded entity, it has undergone a significant transformation. Source: FTV - Q1 2022 Earnings Presentation - April 28, 2022 Segments of its business have been divested [...]
This is my FFJ Portfolio - April 2022 Report. When Warren Buffett worked for Graham-Newman, his mentor (Ben Graham) advised him that: 'In the short run, the market is a voting machine. In the long run, it is a weighing machine. People have been successful investors because they've stuck with successful companies. Sooner or later [...]
Rollins, Inc. (ROL) might not be a recognizable name. Mention Orkin, however, and that is a different story. I think just about everyone in North America has at least seen the Orkin logo at some point. ROL acquired Orkin for $62 million in 1964; the evolution of Rollins is found here. Today, ROL is [...]
In my August 14th Brookfield Asset Management (BAM) stock analysis I disclose the purchase of additional BAM shares through various accounts. In that post, I conclude: 'I have no interest in investing in cryptocurrencies, SPACs, or complex derivative products. I do, however, want exposure to alternative assets thus my reason for investing in BAM.' After [...]
I have been a Visa (V) shareholder almost from the day it went public on March 18, 2008. Over the years I have also increased my exposure. My most recent purchase was made in early March 2022 at which time I acquired shares at ~$195. The number of shares acquired was not meaningful so I [...]
A year has elapsed since I last reviewed Otis Worldwide Corporation (OTIS). At the time, I envisioned a broad market sell-off would lead to a more attractive valuation. Following that post, OTIS's share price skyrocketed and its valuation deteriorated. In early February 2022, I took a quick look at OTIS but still did not like [...]
In my October 20, 2021 post, I disclose a new 30 share position in Intuitive Surgical (ISRG) in a 'Core' account in the FFJ Portfolio and conclude that post by stating that 'Despite shares being grossly overvalued, I think ISRG will be a far more valuable company several years into the future.' I followed [...]
On April 21, 2022 I published my Danaher (DHR) - Creating Long-Term Shareholder Value post. In that post, I touch upon why I deem it to be an attractive long-term investment. I conclude by stating my intent to acquire additional shares even though its valuation is slightly less attractive than at the time of [...]
Danaher (DHR) is creating long-term shareholder value. Over a 10-year timeframe, the average annual total return with the reinvestment of dividends is 22.07% and 21.73% without the reinvestment of dividends. In contrast, the returns from the S&P500 are 14.69% and 13.65% (source: www.tickertech.com). Despite viewing DHR's valuation to be somewhat rich, I initiated a small [...]
I first reviewed LMT in this November 20, 2020 post at which time I disclosed the initiation of a 200 share position @ ~$369/share in one of the 'Core' accounts in the FFJ Portfolio. In subsequent posts (see The FFJ Archives) I disclose additional purchases which have brought my exposure to 455 shares. In my [...]